The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive urinary retention, medical device maker Medtronic announced yesterday.
Called the InterStim smart programmer and designed for use with Medtronic’s InterStim system, the product consists of a Samsung...
